中国口腔颌面外科杂志 ›› 2016, Vol. 14 ›› Issue (3): 213-217.

• 论著 • 上一篇    下一篇

辛伐他汀对唾液腺腺样囊性癌细胞生长及survivin表达的影响

蔡文燕1, 严斐1, 董晶1, 孙晋虎1, 2   

  1. 1.徐州医学院 口腔医学院,江苏 徐州 221004;
    2.徐州医学院附属医院 口腔科,江苏 徐州 221004
  • 收稿日期:2015-11-16 出版日期:2016-06-20 发布日期:2016-07-04
  • 通讯作者: 孙晋虎,E-mail: jinhu-sun@sohu.com
  • 作者简介:蔡文燕(1990-),女,硕士,E-mail:cwywenyan@163.com

Effect of simvastatin on proliferation and apoptosis of salivary adenoid cystic carcinoma SACC-83 cells and survivin expression

CAI Wen-yan1, YAN Fei1, DONG Jing1, SUN Jin-hu1, 2   

  1. 1. School of Stomatology, Xuzhou Medical College. Xuzhou 221004; 2. Department of Stomatology, Affiliated Hospital of Xuzhou Medical College. Xuzhou 221004, Jiangsu Province, China
  • Received:2015-11-16 Online:2016-06-20 Published:2016-07-04

摘要: 目的探讨辛伐他汀(simvastatin)对人唾液腺腺样囊性癌细胞株SACC-83细胞增殖、凋亡及survivin蛋白表达的影响。方法体外培养SACC-83细胞,用不同浓度的辛伐他汀(0、10、20、30、40、50 μmol/L)对体外培养的SACC-83细胞进行不同时间的干预,CCK-8法检测药物对细胞增殖能力的影响;结晶紫染色观察辛伐他汀对细胞集落形成的影响;Annexin-V/PI双染色流式细胞术检测不同浓度辛伐他汀作用于SACC-83细胞48 h后凋亡细胞的百分率;Western蛋白印迹检测 survivin蛋白表达的变化。采用SPSS13.0软件包对数据进行单因素方差分析和q检验。结果用不同浓度的辛伐他汀处理细胞不同时间后,SACC-83的生长受到明显抑制,并具有时间、浓度梯度依赖性;结晶紫染色观察到细胞集落形成也受到抑制(P<0.05);药物处理48 h后,细胞凋亡率随药物浓度增加而升高(从8.60% 到67.97%);同时,SACC-83细胞survivin蛋白的表达量显著降低(P<0.05)。结论辛伐他汀能抑制SACC-83细胞的增殖,诱导细胞凋亡,其机制可能与survivin蛋白的表达下调有关。

关键词: 辛伐他汀, 唾液腺腺样囊性癌, 增殖, 凋亡, Survivin

Abstract: PURPOSE: To investigate the effect of simvastatin on proliferation, apoptosis and expression of survivin in salivary adenoid cystic carcinoma SACC-83 cells. METHODS: SACC-83 cells were cultured in vitro and exposed to different concentrations of simvastatin (0, 10, 20, 30, 40, 50 μmol/L) for 24h and 48h, respectively. Cell survival rate was calculated with CCK-8 assay and the OD values were calculated. Colony formation of SACC-83 cells was observed following a 10-day of exposure to different concentrations of simvastatin. The percentage of apoptotic cells was determined by flow cytometry following annexin-V/Pl staining. At the same time, expression of survivin protein was quantitatively analyzed by Western blotting. The data were analyzed by one-way ANOVA and repeated measurement design using SPSS 13.0 software package. RESULTS: At the concentration of 0, 10, 20, 30, 40, 50 μmol/L, CCK-8 method showed that simvastatin could inhibit the proliferation of SACC-83 cells in a dose- and time-dependent manner. After treatment with simvastatin for 48 h, the IC50 value was 26.27 μmol/L. Simvastatin significantly suppressed the colonization of SACC-83 cell in a dose-dependent manner. Flow cytometry indicated that simvastatin over 10μmol/L increased the cell populations of both the early apoptotic and late apoptotic cells in a dose dependent manner. Simvastatin at 10, 30 and 50 μmol/L resulted in apoptotic percentages of (21.43±5.43)%, (42.8±10.08)%, and (67.97±12.5)%, respectively at 48h of exposure. In addition, simvastatin down-regulated survivin in SACC-83 cells whereas survivin was over-expressed in the untreated SACC-83 cells. The difference was significant (P<0.05). CONCLUSIONS: Simvastatin can significantly inhibit proliferation of SACC-83 cells and induce apoptosis, as indicated by lower-expression of survivin, which suggests that survivin might serve as a novel target in the therapy for salivary adenoid cystic carcinoma.

Key words: Simvastatin, Salivary adenoid cystic carcinoma, Proliferation, Apoptosis, Survivin

中图分类号: